Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Impaired NF-kappaB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts.
Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection.
Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials.
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients.
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. J Clin Oncol. 2009 Sep 20; 27(27):4462-8.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Benzenesulfonates
Carcinoma, Renal Cell
Female
Humans
Imidazoles
Indazoles
Kidney Neoplasms
Male
Middle Aged
Niacinamide
Phenylurea Compounds
Pyridines
authors with profiles
Walter M. Stadler